University of Magdeburg
uni-magdeburg.deLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
35
Active
0
Phase 3
1
Total enrollment
1,040,112
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Stroke4
- Glaucoma3
- Hemianopia3
- Colorectal Cancer2
- Liver Metastases2
- Electrical Stimulation2
- Prostate Cancer2
- Hepatocellular Carcinoma2
Frequently asked questions about University of Magdeburg
- How many clinical trials does University of Magdeburg have on ClinicalTrials.gov?
- University of Magdeburg is listed as the lead sponsor on 35 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Magdeburg's trials are in Phase 3?
- 1 of University of Magdeburg's trials are in Phase 3.
- What therapeutic areas does University of Magdeburg focus on?
- University of Magdeburg's most-studied conditions on ClinicalTrials.gov are Stroke, Glaucoma, Hemianopia, Colorectal Cancer, Liver Metastases.